Language selection

Government of Canada / Gouvernement du Canada

Search

Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.: HP5-142/1-2022E-1-PDF ; HP5-142/2-2022E-1-PDF

"On June 29, 2022, NACI published interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada. The statement outlined recommendations for booster doses in specific populations ahead of the uncertain trajectory of the COVID-19 pandemic in the coming months"--Background, page 3.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.915979&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
TitleRecommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.
Publication typeMonograph
Language[English]
Other language editions[French]
Earlier editionRecommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Recommandations sur l'utilisation des vaccins à ARNm bivalents contre la COVID-19 contenant le variant Omicron.
  • At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Updated: October 7, 2022."
  • Includes bibliographical references (pages 17-22).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, September 1, 2022.
  • ©2022
Description1 online resource (27 pages) + 1 summary (8 pages)
ISBN9780660457246 9780660457253
Catalogue number
  • HP5-142/1-2022E-1-PDF
  • HP5-142/2-2022E-1-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: